Lin et al. (2019) showed that downregulation of USP34 could inhibit proliferation and migration in pancreatic cancer cells and inactivate p38 MAPK signaling via inhibiting PRR11. It demonstrated that these signaling pathways are not common pathways for PRR11 to play a promotional role in pan-cancer. Here, USP34 is linked to pancreatic neoplasm.